Effect of Multitarget tDCS for Neuropathic Pain
NCT: NCT06510725 · COMPLETED
NCT IDNCT06510725
StatusCOMPLETED
Start Date2024-09-01
Completion2026-08-25
SponsorXuanwu Hospital, Beijing (OTHER)
First posted
Last updated
Brief Summary
This study aims to conduct a randomized controlled trial to evaluate the effect of multitarget transcranial direct current stimulation (tDCS) on pain, depression, anxiety, quality of life and sleep, in patients with neuropathic pain.
Frequently Asked Questions
What is Effect of Multitarget tDCS for Neuropathic Pain?
Effect of Multitarget tDCS for Neuropathic Pain is a clinical trial registered under NCT06510725. Current status: COMPLETED.
What is the status of NCT06510725?
The current status of NCT06510725 (Effect of Multitarget tDCS for Neuropathic Pain) is: COMPLETED.
When did Effect of Multitarget tDCS for Neuropathic Pain start?
Effect of Multitarget tDCS for Neuropathic Pain started on 2024-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.